SUZHOU, China, Aug. 28, 2024 /PRNewswire/ — Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its wholly-owned subsidiary, Achieva Medical Limited (“Achieva Medical”),…
Neuro
New Research Published in Nature Medicine Highlights the Benefit of Anti-Blood Clot Medications to Prevent Stroke Among Patients Undergoing Non-Cardiac Surgery
Risk Predication Tool, Developed by Anesthesiologists at Montefiore Health System and Albert Einstein College Medicine, May Reduce Adverse Outcomes BRONX, N.Y., Aug. 23, 2024 /PRNewswire/ — A new computational risk assessment prediction tool developed by anesthesiologists at Montefiore…
Bioxodes reports positive DMC meeting for BIOX-101 Phase 2a trial in intracerebral hemorrhagic stroke
Gosselies (Belgium), August 21, 2024 – Bioxodes SA, a clinical stage biopharmaceutical company developing novel therapies to prevent and treat thrombotic and inflammatory diseases, announces today that the DMC reviewed the data from the first 8 patients in a planned review of the ongoing BIRCH Phase 2a trial of BIOX-101 to prevent secondary damage after intracerebral hemorrhagic stroke (ICH).
MemorialCare’s Long Beach Medical Center and Saddleback Medical Center Nationally Recognized by the American Heart Association with Get with the Guidelines Gold Plus Awards
FOUNTAIN VALLEY, Calif., Aug. 20, 2024 /PRNewswire/ — MemorialCare’s Long Beach Medical Center and Saddleback Medical Center received the American Heart Association’s Get With The Guidelines® – Stroke Gold Plus quality achievement awards. Long Beach Medical Center also received the Get…
Bracco Imaging S.p.A. and BURL Concepts, Inc. Form Strategic Partnership to Revolutionize Stroke Care
Innovative Collaboration to Enhance Ischemic Stroke Detection and Patient Care, Elevating Standards in Diagnostic Imaging MILAN and SAN DIEGO, July 31, 2024 /PRNewswire/ — Bracco Imaging S.p.A., part of the Bracco Group, a global leader in the field of diagnostic imaging solutions, and…
Acticor Biotech Announces the Conclusions of the Interim Futility Analysis in the GREEN Study
July 26, 2024 02:00 AM Eastern Daylight Time PARIS–(BUSINESS WIRE)–Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 – ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, announces the conclusions of the futility analysis of […]
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks
The studies presented this week at the Society of Neurointerventional Surgery (SNIS) underline the company’s rigorous evidence-based approach to developing and validating novel AI solutions that can help to optimize patient care across stroke networks. OXFORD, England and CHICAGO, July…
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
Late-Breaking Data Presented at SNIS Suggest Lower Rates of Rescue Therapy Than Prior Thrombectomy Trials; Rapid Reperfusion Time; High Rates of Reperfusion July 24, 2024 01:30 PM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that late-breaking data […]
TeleSpecialists’ Groundbreaking AI-Focused Stroke Research Published in Frontiers in Stroke Journal
Collaborative research highlights the significance of AI-powered care coordination in acute stroke management FORT MYERS, Fla., July 24, 2024 /PRNewswire/ — TeleSpecialists, LLC, the largest inpatient provider of TeleStroke and TeleNeurology services in the nation, announced the…
MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms
COLORADO SPRINGS, Colo. & ALISO VIEJO, Calif.–(BUSINESS WIRE)–MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced the recently published results of the CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness […]